AnodyneWiki

Amifampridine

Amifampridine
Amifampridine
Salts
[]
Amifampridine phosphate
Amifampridine phosphate
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass109.13 g/mol [1]
Melting point229 ± 2 [1]
Solubilityfreely soluble in water, and slightly soluble in solvents ethanol, methanol and acetic acid [1]
Predicted LogP-0.5 [1]
Structural Identifiers
[]
Molecular formulaC5H7N3
IUPAC namepyridine-3,4-diamine
SMILESC1=CN=CC(=C1N)N
InChIInChI=1S/C5H7N3/c6-4-1-2-8-3-5(4)7/h1-3H,7H2,(H2,6,8)
InChIKeyOYTKINVCDFNREN-UHFFFAOYSA-N
CAS number54-96-6
UNIIRU4S6E2G0J
PubChem CID5918
Pharmacokinetics[]
Elimination half-life2.5 hours (amifampridine), 4 hours (3-N-acetyl­amifampridine)
MetabolismAcetylation to 3-N-acetyl­amifampridine
ExcretionKidney (19% unmetabolized, 74–81% 3-N-acetyl­amifampridine)
Routes of administrationBy mouth

Amifampridine (also known as 3,4-Pyridinediamine, 4,5-Diaminopyridine, 3,4-dap, Pyridine, 3,4-diamino-, amifampridina, SC10, 3,4 Diaminopyridine, amifampridinum, 5-22-11-00266 (Beilstein Handbook Reference) or N07xx05).

Chemistry

Salts []

Amifampridine is typically found in the form of its phosphate salt.

 []

Amifampridine is achiral.

Amifampridine matches Lipinski's rule of five.

Pharmacology

Mechanism of action []

Amifampridine is a symptomatic treatment that increases acetylcholine concentrations at the neuromuscular junction. It selectively blocks presynaptic fast voltage-gated potassium channels, thereby prolonging cell membrane depolarization and action potential, and augmenting calcium transport into the nerve endings. Increased intracellular calcium enhances the exocytosis of acetylcholine-containing vesicles and enhances impulse transmission at central, autonomic, and neuromuscular synapses. Amifampridine improves muscle strength and resting compound muscle action potential (CMAP) amplitudes with an overall weighted mean difference of 1.69 mV. [1]

 []

  • Australia: Amifampridine is a Schedule 4.[3]
  • Canada: Amifampridine is Prescription only.[4][5]
  • United Kingdom: Amifampridine is Prescription only.
  • United States: Amifampridine is Prescription only.
  • European Union: Amifampridine is Prescription only.

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 5918, Amifampridine. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/5918
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Amifampridine. UNII: RU4S6E2G0J. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/RU4S6E2G0J
  3. Ruzurgi APMDS. Therapeutic Goods Administration (TGA). 24 September 2021. https://www.tga.gov.au/resources/auspmd/ruzurgi
  4. Summary Basis of Decision (SBD) for Firdapse. Health Canada. 23 October 2014. https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?linkID=SBD00503&lang=en
  5. Summary Basis of Decision (SBD) for Ruzurgi. Health Canada. 23 October 2014. https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?linkID=SBD00501&lang=en

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 11:01:02
drugspromissing (no DrugsPRO reagent data)2026-11-20 11:00:58
erowidmissing (no Erowid substance of that name)2026-11-20 11:00:58
gsrsok2026-11-20 11:00:58
hmdbmissing (hmdb.ca refused automated access to HMDB0246022)2026-11-20 11:00:58
keggok2026-11-20 11:00:59
pubchemok2026-11-20 11:00:57
redditmissing (no r/tripreports posts mention it)2026-11-20 11:00:58
sidermissing (not in SIDER)2026-11-20 11:00:58
structureok2026-11-20 11:00:58
wikipediaok2026-11-20 11:00:58